Eren, Ozan E. http://orcid.org/0000-0002-5299-388X
Schöberl, Florian
Schankin, Christoph J.
Straube, Andreas
Funding for this research was provided by:
Baasch Medicus Foundation
Deutsche Migräne- und Kopfschmerzgesellschaft
Eye on Vision Foundation
Friedrich-Baur Foundation
Article History
Received: 9 August 2020
Accepted: 10 September 2020
First Online: 16 September 2020
Compliance with ethical standards
:
: OE Eren has received honoraria for consulting within the past three years from Novartis Pharma. FS has nothing to report. CJ Schankin has received honoraria for consulting and lectures within the past 3 years from Novartis, Eli Lilly, Allergan, Almirall, Amgen, Teva Pharmaceuticals, MindMed, and Grünenthal outside the submitted work. AS has received honoraria for consulting and lectures within the past 3 years from Allergan Pharma, Bayer, Lilly, Novartis Pharma, Sanofi, and TEVA.
: The work was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of the Ludwig Maximilians University Munich (227-15). The subject was recruited between 2015 and 2017 and gave written informed consent.
: Not applicable.